Avoid injecting into: Skin that is bruised, tender, scarred, or affected by a rash Areas with visible lipohypertrophy or lipoatrophy (sunken skin) The waistband area or near bony prominences If you notice persistent lumps, skin changes, or unusual discomfort at injection sites, report these to your healthcare professional promptly
The full prescribing information is available via FDA's accessdata portal
57 formats across 8 categories: lyophilized powder, injectables, capsules, nasal spray, transdermal patch, sublingual troche, topical serum, and multi-compound research stacks all independently tested
The development of predictive biomarkers to identify patient subgroups that would benefit most from these therapies represents a crucial unmet need
That is the actual decision in front of anyone considering it, and it should be made with that asymmetry in full view, in conversation with a physician who can at least monitor the liver the market will not